Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2.

Source:http://linkedlifedata.com/resource/pubmed/id/18413606

Proc. Natl. Acad. Sci. U.S.A. 2008 Apr 15 105 15 5850-5

Download in:

View as

Triples

General Info

PMID
18413606